Valuation Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 03:35:37 2026-08-18 pm EDT			5-day change	1st Jan Change
242.15 ^EUR	+0.52%		+2.76%	+43.09%

Aug. 13	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
Aug. 10	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	13,684	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	36.52%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	15,796	15,315	14,921
Change	-	-36.28%	7.39%	-20.91%	3.29%	32.23%	-3.05%	-2.57%
P/E	49.4x	23.1x	25.9x	931x	-70x	76.7x	30.7x	27.5x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	4.54x	3.86x	3.43x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0x	2.4x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	3.5x	3.42x	3.25x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	4.04x	3.83x	3.55x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	15.7x	14x	12.7x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	19.2x	16.8x	14.9x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	50.1x	25.1x	31.3x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	2%	3.98%	3.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	3.738	9.346	10.43
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,911	4,001	4,208
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,008	1,093	1,174
EBIT ¹	742.1	834	838.8	805.9	793.9	821	912.3	1,001
Net income ¹	391	486.2	474.6	10.3	-144.3	162.5	427.8	471.2
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	2,112	1,631	1,237
Reference price ²	375.34	218.92	238.84	186.16	203.66	286.64	286.64	286.64
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	47,739	-	-
Announcement Date	2/16/22	2/22/23	2/14/24	2/19/25	2/18/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	33.26x	5.94x	17.67x	0.96%	48.84B
REVOLUTION MEDICINES, INC.	-22x	301.52x	-22.38x	-.--%	45.44B
BEONE MEDICINES AG	47.49x	5.5x	30.07x	-.--%	41.22B
IQVIA HOLDINGS INC.	31.07x	3.07x	13.27x	-.--%	39.71B
CELLTRION, INC.	30.58x	8.82x	22.17x	0.38%	32.6B
MEDPACE HOLDINGS, INC.	33.96x	5.56x	25.28x	-.--%	16.67B
EUROFINS SCIENTIFIC SE	23.34x	2.04x	8.84x	1.15%	14.08B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	76.69x	4.04x	15.66x	-.--%	13.68B
Average	31.80x	42.06x	13.82x	0.31%	31.53B
Weighted average by Cap.	26.79x	58.69x	12.27x	0.3%